ArticleInternational journal of health policy and management2024
Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures.
Article in International journal of health policy and management, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Conflicts of interest as a barrier to the development of health technology assessment in Iran: a qualitative study.Journal of health, population, and nutrition · 2026Article
- Rethinking revolving door research: a scoping review of methods and datasets used by non-academics to examine the revolving door.Globalization and health · 2026Article
- Lobbying in the Shadows: A Comparative Analysis of Government Lobbyist Registers.The Milbank quarterly · 2025Article
- An analysis of submissions on regulations to implement Aotearoa New Zealand's tobacco endgame policies.Health promotion international · 2025Article
- Alcohol lobbying in Canada: a quantitative analysis of the federal registry of lobbyists.Health promotion international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile anyone can lobby governments, most lobbying is driven by commercial interests. Due to limited government disclosures, it is often challenging to get a clear picture of who is lobbying whom or why. To help make lobbying more visible to the public, we set out to develop a framework of key criteria for best practice government lobbying disclosures.
methodsWe undertook a systematic scoping review of peer-reviewed and grey literature to identify frameworks for measuring or evaluating lobbying transparency. We screened the titles and abstracts of 1727 peer-reviewed and 184 grey literature articles, assessing 230 articles for eligibility. Following screening, we included 15 frameworks from six peer-reviewed and nine grey literature articles in our review. To create our framework of lobbying disclosures, we thematically coded the 15 included frameworks and used an iterative process to synthesise categories.
resultsThe 15 frameworks covered more than only lobbying disclosures, with the most common other theme about enforcement and compliance. Most frameworks were developed to evaluate lobbying transparency in particular jurisdictions, with the United States the most common. Of the 15 frameworks analysed, those developed by non-governmental organizations (NGOs) focused mainly on improving lobbying regulations, while most peer-reviewed studies developed frameworks to measure, compare and evaluate lobbying regulations. We developed a Framework fOr Comprehensive and Accessible Lobbying (FOCAL). It comprised eight primary categories (scope, timeliness, openness, descriptors, revolving door, relationships, financials, and contact log) covering 50 total indicators.
conclusionGovernment transparency plays a crucial role in facilitating access to information about commercial political activities like lobbying. Our framework (FOCAL) offers a template for policy-makers to develop or strengthen regulations to improve lobbying transparency so commercial political influence strategies are more visible and subject to public scrutiny. This is an important step towards rebalancing influence toward the public interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.